IV nutrition may change blood clotting, large study finds
NCT ID NCT07470385
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 2 times
Summary
This completed observational study looked at how intravenous lipid emulsions (fat-containing nutrition given through a vein) affect blood clotting in 6,259 hospitalized patients. Researchers compared clotting tests before and after patients received these emulsions as part of routine care. The goal is to understand any changes in clotting function, which could help guide safer use of IV nutrition in hospitals.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- intravenous lipid emulsions (fat-containing nutrition given through a vein)
- What this could lead to
- If it shows a clear effect, this could help doctors better understand how IV nutrition affects blood clotting and guide safer use in hospitals.
- What could go wrong
- This is an observational study, so it can only show links, not cause and effect. Results may be influenced by other factors and may not apply to all patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COAGULATION DISORDER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Department of Pharmacy, Xiangya Hospital, Central South University
Changsha, Hunan, 410028, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- New trial aims to stop deadly bleeding after birth
- Massive study aims to crack the code on Kids' medications
- New reversal agent TAK-330 aims to stop bleeding in emergency surgeries
- New drug aims to stop bleeding in emergency surgeries for blood thinner users
- Cancer patients face higher clot risk – new study aims to understand why
- Experimental clotting agent VMX-C001 tested with common blood thinners